News & Views
Laboratory scientists explore 'glowing' tumour detection
Apr 29 2010
Researchers at Vanderbilt University are using imaging agents in tumours that will cause specific parts to light up as they begin to form.
Fluorescent inhibitors of the enzyme cyclooxygenase-2 (COX-2) can be spotted at the pre-malignancy stage and may help to track the progress of the disease.
Commenting on the development, Dr Lawrence Marnett said he and his team are "very excited" and they are looking to perform human trials as soon as possible.
"It was a real challenge to make a compound that is COX-2 selective (doesn't bind to the related COX-1 enzyme), has desirable fluorescence properties and gets to the tissue in vivo," he explained.
Laboratory scientists recently revealed that twice as many Swedish people survive lung cancer than Brits with the disease.
According to the experts, a lack of awareness regarding the symptoms could be delaying treatment in the UK, leading to higher mortality rates.
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
Apr 28 2024 Montreal, Quebec, Canada
May 05 2024 Seville, Spain
InformEx Zone at CPhl North America
May 07 2024 Pennsylvania, PA, USA
May 14 2024 Oklahoma City, OK, USA
May 15 2024 Birmingham, UK